Literature DB >> 6443045

Basis of cellular autonomy in the susceptibility to carcinogenesis.

J Russo.   

Abstract

This paper summarizes our contributions in the basic understanding of the different susceptibility of the mammary gland to carcinogenesis according to age and parity history. Mammary carcinomas induced by the administration of 7,12-dimethylbenz-(DMBA) to young virgin rats arise from undifferentiated terminal ductal structures called terminal end buds (TEBs). TEBs, that normally differentiate into alveolar buds (ABs) and lobules, under the influence of DMBA develop intraductal proliferations which progress to carcinoma. The high susceptibility of the young virgin rat TEBs to neoplastic transformation is due to its large proliferative compartment, with cells cycling every 10 hours, and to a higher 3H-DMBA uptake. Progressive differentiation of TEBs into ABs and lobules or their regression to terminal ducts (TDs) is seen with aging. Complete differentiation of the gland is attained through pregnancy and lactation or through exogenous administration of chorionic gonadotrophin. The greater differentiation of the gland is manifested as permanent structural changes, consisting in the disappearance of TEBs and in a diminution of the number of TDs due to their differentiation into ABs and lobules. This greater differentiation results in a diminished or total refractoriness of the gland to the carcinogen because ABs and lobules have a lower proliferative compartment, and a longer cell cycle than TEBs and TDs. Cells of parous rats have both in vivo and in vitro lower DMBA-DNA binding capacity, lower DNA synthesis and greater ability to repair DMBA-damaged DNA than cells of young virgin rats. The more efficient DNA repair capacity of the parous rat mammary gland is demonstrated by the induction of unscheduled DNA synthesis and a removal of DMBA-DNA adducts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6443045     DOI: 10.1177/019262338301100207

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  9 in total

Review 1.  Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?

Authors:  Denise K Reaves; Erika Ginsburg; John J Bang; Jodie M Fleming
Journal:  Endocr Relat Cancer       Date:  2015-01-26       Impact factor: 5.678

2.  Structure-activity relationships in the induction of mammary gland neoplasia in male rats with substituted aminopyrazoles.

Authors:  J E Fitzgerald; E J McGuire; L K Andrews; F A de la Iglesia
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

3.  Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.

Authors:  I H Russo; J Frederick; J Russo
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

Review 4.  Experimentally induced mammary tumors in rats.

Authors:  J Russo; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 5.  Mammary gland neoplasia in long-term rodent studies.

Authors:  I H Russo; J Russo
Journal:  Environ Health Perspect       Date:  1996-09       Impact factor: 9.031

6.  Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.

Authors:  I H Russo; M Koszalka; P A Gimotty; J Russo
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

7.  Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.

Authors:  I H Russo; P Gimotty; M Dupuis; J Russo
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

8.  Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis.

Authors:  I H Russo; M Koszalka; J Russo
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

9.  Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.

Authors:  Raúl M Luque; Alicia Villa-Osaba; Fernando L-López; Ana I Pozo-Salas; Rafael Sánchez-Sánchez; Rosa Ortega-Salas; Luis de Lecea; Marina Álvarez-Benito; José López-Miranda; Manuel D Gahete; Justo P Castaño
Journal:  Breast Cancer Res       Date:  2016-03-08       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.